Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer.
about
PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathwayThe FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumorsHuman acid ceramidase is overexpressed but not mutated in prostate cancerMolecular regulation of human cathepsin B: implication in pathologiesFrequent occurrence of uniparental disomy in colorectal cancer.Regulatory subunits of PKA define an axis of cellular proliferation/differentiation in ovarian cancer cellsThe cellular and molecular basis of prostate cancer.Chromosomal basis of adenocarcinoma of the prostate.Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22.High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genesLinkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25.PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.Matching cancer genomes to established cell lines for personalized oncology.PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.Deletion mapping and linkage analysis provide strong indication for the involvement of the human chromosome region 8p12-p22 in breast carcinogenesisA defect in the TUSC3 gene is associated with autosomal recessive mental retardationLeucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.Novel autosomal recessive non-syndromic hearing impairment locus (DFNB71) maps to chromosome 8p22-21.3.Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.Tumor suppressor candidate 3 as a novel predictor for lymph node metastasis in lung cancer patients.TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling.TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.TUSC3: a novel tumour suppressor gene and its functional implications.Methylation status of TUSC3 is a prognostic factor in ovarian cancer.High-density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8p.Quantitative detection of TUSC3 promoter methylation -a potential biomarker for prognosis in lung cancer.Tumour-suppressor genes in prostatic oncogenesis: a positional approach.Vitamin D receptor-binding site variants affect prostate cancer progression.The Genomics of Prostate Cancer: emerging understanding with technologic advances.Association between the PINX1 and NAT2 polymorphisms and serum lipid levels.Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostate.Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma.
P2860
Q21245756-001CC3E7-F249-4817-988A-ED09CD14F2E2Q22009112-4D39E99D-5857-4489-8BDD-A0EEB843E5DCQ28144553-E3AA424D-FC2B-4A16-844B-58D285E0A292Q28190363-94FAC0CF-ABCD-4620-AD55-E51179A426B2Q33246807-50B3D671-1C19-4BDC-B750-45FF51D8766EQ33372446-371E78F0-F984-495C-80E9-BDD8E4DEAB17Q33610876-92CEA980-5D4F-43C9-B481-E7E291ED1626Q33704075-B013C502-373F-4318-9085-2D3B329E0272Q34084574-61C577D4-6391-4FC8-8F45-06135078CD2CQ35025252-64801302-87C8-4F6E-8705-65813FF8947CQ35085978-AAF0CFC5-4A5F-4F90-A415-AD92B706B750Q35249155-DEC4985D-0F01-4FAD-915A-B80F55AEA17AQ35497283-D9B53B42-358F-4397-8759-26E439ED6891Q36336519-51E2CE91-1ECB-4C1A-95FB-1AA79A78F83DQ36356348-48DABD34-3A22-4B10-84F2-7F844C511640Q36431232-8BC5588A-C361-4D42-A5D5-E2170BEA979FQ37118375-1FE3B003-F896-4875-93A5-4BD3BA0C3BC9Q37122827-63F273B2-2592-4C74-9735-494492F3D119Q37354421-7810B0FE-C561-4560-80D2-7D578E1874C8Q37513467-ABC3A19E-0BED-4967-B742-9E0F18108F88Q37582374-CCB5E66D-1C46-4BBA-9E13-3B707AC529C8Q38737107-5E1E2F14-8753-44AA-B8F5-C730094823F6Q38778821-0400919E-4658-4F37-8AE4-78A2CA09026CQ39033641-4EA2A157-FE51-41BF-92D6-5F938F4F677FQ39168284-4DC532B0-0C2B-4178-AFB7-CE609A16534FQ39253858-2E60FA18-BAB0-47C2-A952-E486B3C65E56Q40979749-C350BA58-0CDC-4BB5-BB55-C44918013CABQ41195127-51EED0FC-AD1B-44B2-94D5-75CF1413AE98Q41409406-D4E429B4-67E1-47B7-AA83-BEA3A517C84EQ47110997-A1B12ABD-DCCC-4A0B-99D0-591FD3F7F225Q48317607-D6BADBB4-795F-4358-9BDA-374B34E2060CQ49294719-B0C0D773-E20B-41B7-9E1D-433FB9CE9736Q52874494-5564AADD-8A5C-4475-A665-4CD276483E7DQ55473683-FDE07845-3094-48F9-B8AB-19CB61F2A679
P2860
Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Physical mapping of chromosome ...... a metastatic prostate cancer.
@en
Physical mapping of chromosome ...... a metastatic prostate cancer.
@nl
type
label
Physical mapping of chromosome ...... a metastatic prostate cancer.
@en
Physical mapping of chromosome ...... a metastatic prostate cancer.
@nl
prefLabel
Physical mapping of chromosome ...... a metastatic prostate cancer.
@en
Physical mapping of chromosome ...... a metastatic prostate cancer.
@nl
P2093
P356
P1433
P1476
Physical mapping of chromosome ...... n a metastatic prostate cancer
@en
P2093
P356
10.1006/GENO.1996.0321
P577
1996-07-01T00:00:00Z